STAT3 and cancer: STAT3 (signal transducer and activator of transcription 3) is key in regulating the anti-tumor immune response and a therapeutic target of immune therapies in different cancer subtypes such as celecoxib in colorectal cancer and pyrimethamine in chronic lymphocytic leukemia (Zou et al., 2020).